Unknown PHASE4 INTERVENTIONAL 1-arm NCT01935193

Aspirin Resistance Reversibility in Diabetic Patients (ARRDM)

Impact of Different Pharmacological Formulations on Aspirin Resistance Reversibility in Diabetics Patients

Sponsor: Azienda Ospedaliera San Giovanni Battista

Updated 5 times since 2017 Last updated: Aug 30, 2013 Started: Nov 30, 2011 Primary completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Aspirin Resistance, this trial is ongoing. The trial is conducted by Azienda Ospedaliera San Giovanni Battista and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera San Giovanni Battista

Data source: Azienda Ospedaliera San Giovanni Battista

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Torino, Italy